These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 12584173

  • 1. 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer.
    Wu J, Xia HH, Tu SP, Fan DM, Lin MC, Kung HF, Lam SK, Wong BC.
    Carcinogenesis; 2003 Feb; 24(2):243-7. PubMed ID: 12584173
    [Abstract] [Full Text] [Related]

  • 2. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 3. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
    Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM.
    J Natl Cancer Inst; 2000 Jul 19; 92(14):1136-42. PubMed ID: 10904086
    [Abstract] [Full Text] [Related]

  • 4. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.
    Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9968-73. PubMed ID: 12909723
    [Abstract] [Full Text] [Related]

  • 5. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.
    Liu SH, Shen CC, Yi YC, Tsai JJ, Wang CC, Chueh JT, Lin KL, Lee TC, Pan HC, Sheu ML.
    Br J Pharmacol; 2010 Aug 19; 160(8):1963-72. PubMed ID: 20649594
    [Abstract] [Full Text] [Related]

  • 6. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.
    Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM.
    Cancer Res; 2001 Jun 15; 61(12):4879-84. PubMed ID: 11406566
    [Abstract] [Full Text] [Related]

  • 7. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
    Jiang XH, Lam SK, Lin MC, Jiang SH, Kung HF, Slosberg ED, Soh JW, Weinstein IB, Wong BC.
    Oncogene; 2002 Sep 05; 21(39):6113-22. PubMed ID: 12203123
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q, Luo X, Huang Y, Sheikh MS.
    Oncogene; 2002 Sep 05; 21(39):6032-40. PubMed ID: 12203115
    [Abstract] [Full Text] [Related]

  • 10. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE, Elder DJ, Paraskeva C.
    Carcinogenesis; 2000 Jan 05; 21(1):69-77. PubMed ID: 10607736
    [Abstract] [Full Text] [Related]

  • 11. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG, Martinez JM, Alston-Mills B, Eling TE.
    Carcinogenesis; 2004 Mar 05; 25(3):349-57. PubMed ID: 14633654
    [Abstract] [Full Text] [Related]

  • 12. The 15-lipoxygenase-1 expression may enhance the sensitivity to non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancers from patients who are treated with the compounds.
    Yoshinaga M, Murao H, Kitamura Y, Koga K, Tsuruta S, Igarashi H, Nakamura K, Takayanagi R.
    J Gastroenterol Hepatol; 2007 Dec 05; 22(12):2324-9. PubMed ID: 17559385
    [Abstract] [Full Text] [Related]

  • 13. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
    Raju U, Nakata E, Yang P, Newman RA, Ang KK, Milas L.
    Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):886-94. PubMed ID: 12377342
    [Abstract] [Full Text] [Related]

  • 14. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY, Zhang L, Jiang Y, Farber JL.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):40-50. PubMed ID: 15632379
    [Abstract] [Full Text] [Related]

  • 15. Expression of 15-lipoxygenase-1 in human colorectal cancer.
    Ikawa H, Kamitani H, Calvo BF, Foley JF, Eling TE.
    Cancer Res; 1999 Jan 15; 59(2):360-6. PubMed ID: 9927047
    [Abstract] [Full Text] [Related]

  • 16. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.
    Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM.
    Neoplasia; 2003 Jan 15; 5(2):121-7. PubMed ID: 12659684
    [Abstract] [Full Text] [Related]

  • 17. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.
    Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, Brenner DE.
    Carcinogenesis; 1999 Oct 15; 20(10):1985-95. PubMed ID: 10506115
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF.
    Reddy N, Everhart A, Eling T, Glasgow W.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):111-6. PubMed ID: 9070230
    [Abstract] [Full Text] [Related]

  • 19. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL.
    J Surg Res; 1999 Jan 03; 81(1):101-7. PubMed ID: 9889067
    [Abstract] [Full Text] [Related]

  • 20. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL, Wu YL, Zhang YP, Qiao MM, Chen Y.
    World J Gastroenterol; 2004 Jul 01; 10(13):1971-4. PubMed ID: 15222049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.